No Data
TD Cowen Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $165
Stifel Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $166
H.C. Wainwright Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $168
Neurocrine Is Maintained at Buy by HC Wainwright & Co.
With EPS Growth And More, Neurocrine Biosciences (NASDAQ:NBIX) Makes An Interesting Case
In The Holiday Shortened Easter Week, These Large-Cap Stock Were Top Performers (Apr 14-Apr 18): Are These In Your Portfolio?
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}